Sangamo Therapeutics所有资讯

Sangamo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)

04/06 04:04

Sangamo Therapeutics | PRE 14A：并购重组委托声明

04/04 05:21

Sangamo Therapeutics | 8-K：重大事件

03/26 05:09

Sangamo Therapeutics | 424B5：募资说明书

03/26 04:06

Sangamo Therapeutics | 8-K：SANGAMO THERAPEUTICS公布了最近的业务亮点以及2023年第四季度和全年财务业绩

03/13 19:58

Sangamo Therapeutics | 10-K：年度报表

03/13 19:53

Sangamo Therapeutics | 4：持股变动声明-高管 Duraibabu Prathyusha

02/28 06:18

Sangamo Therapeutics | 4：持股变动声明-高管 Dubois-Stringfellow Nathalie

02/28 06:18

Sangamo Therapeutics | 4：持股变动声明-高管 Willoughby Scott B.

02/28 06:17

Sangamo Therapeutics | 4：持股变动声明-高管 Pooler Amy

02/28 06:17

Sangamo Therapeutics | 4：持股变动声明-高管 Macrae Sandy

02/28 06:17

Sangamo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(7.10%)

02/14 11:36

Sangamo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Biogen Inc.(8.26%),Biogen MA Inc.(8.26%)

02/13 08:15

Sangamo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)

02/10 01:20

Sangamo Therapeutics | 8-K：重大事件

02/07 05:39

Sangamo Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(7.9%)

01/27 00:54

Sangamo Therapeutics | 4：持股变动声明-高管 Pooler Amy

01/25 05:46

Sangamo Therapeutics | 4：持股变动声明-高管 Willoughby Scott B.

01/25 05:45

Sangamo Therapeutics | 4：持股变动声明-高管 Duraibabu Prathyusha

01/25 05:45

Sangamo Therapeutics | 4：持股变动声明-高管 Dubois-Stringfellow Nathalie

01/25 05:45